Ariel Karwat
Nurse Practitioner · Brooklyn, NYNPI 1427648179
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,433 of the $1,653 with a category attached, or 86.7%. It is spread thinly across 26 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 62 payments — averaging $26.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$274
- Recordati_rare_diseases_inc.$163
- Lilly USA, LLC$151
- Incyte Corporation$120
- Stemline Therapeutics Inc.$102
- E.r. Squibb & Sons, L.L.C.$90
- plus $752 from 20 others
What the payments were for
- Food & beverage$1,43387%
- Education$22013%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 12 | $274 |
| Recordati_rare_diseases_inc. | 3 | $163 |
| Lilly USA, LLC | 2 | $151 |
| Incyte Corporation | 2 | $120 |
| Stemline Therapeutics Inc. | 5 | $102 |
| E.r. Squibb & Sons, L.L.C. | 4 | $90 |
| Johnson & Johnson | 4 | $86 |
| Myriad Genetic Laboratories, Inc. | 1 | $61 |
| Amgen | 2 | $59 |
| Merck | 2 | $53 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $50 |
| AstraZeneca(2 entities) | 3 | $49 |
| Seagen Inc. | 3 | $49 |
| Daiichi Sankyo Inc. | 2 | $48 |
| Sanofi | 2 | $44 |
| Deciphera Pharmaceuticals Inc. | 1 | $41 |
| Bristol Myers Squibb | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Gilead | 1 | $29 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
| AMAG Pharmaceuticals, Inc. | 1 | $18 |
| Taiho Oncology, Inc. | 1 | $17 |
| Pharmaessentia USA Corporation | 1 | $17 |
| Myovant Sciences Inc. | 1 | $16 |
| EMD Serono, Inc. | 1 | $15 |
| Epizyme, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Sylvant$125
How this compares
$1,653 in reported general payments places this provider in the 90th percentile of 4,112 nurse practitioner providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisone | 11 | $39 |
| Ondansetron Hcl | 12 | $35 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Brooklyn
- Velta WillisBrooklyn$19K
- Patricia McGoldrickNew York$202K
- Michelle DartSyracuse$95K
- Susan KreppelWilliamsville$67K
- Kerry AhernEast Syracuse$55K
- Valerie StanleyAlbany$55K
- Jodi LogerfoNew York$48K
- Grace WlasowiczRochester$41K
- Melissa LevinElmhurst$34K
- Carla JungquistCanandaigua$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.